BlackRock
WX

BlackRock’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

BlackRock’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-427,489
Closed -$18.5M – 3570
2015
Q3 		$18.5M Sell
427,489
-21,265
-5% -$897K 0.03% 524
2015
Q2 		$19M Buy
448,754
+84,652
+23% +$3.57M 0.03% 535
2015
Q1 		$14.1M Buy
364,102
+89,884
+33% +$3.46M 0.02% 610
2014
Q4 		$9.23M Buy
274,218
+139,572
+104% +$4.93M 0.01% 702
2014
Q3 		$4.72M Buy
134,646
+78,121
+138% +$2.68M 0.01% 832
2014
Q2 		$1.86M Buy
56,525
+13,806
+32% +$472K ﹤0.01% 1058
2014
Q1 		$1.57M Buy
42,719
+20,814
+95% +$764K ﹤0.01% 1096
2013
Q4 		$841K Sell
21,905
-2,388
-10% -$75.4K ﹤0.01% 1209
2013
Q3 		$666K Sell
24,293
-285
-1% -$6.75K ﹤0.01% 1178
2013
Q2 		$516K Buy
+24,578
New +$480K ﹤0.01% 1217

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

BlackRock's WX Position: Q4 2015 in Review

BlackRock sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 427,489 shares — an estimated $18.5M sold.

BlackRock first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $19M in Q2 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • BlackRock reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • BlackRock sold 427,489 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $18.5M.
  • BlackRock first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
  • BlackRock's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $19M in Q2 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on BlackRock's 13F filing for Q4 2015, filed 11 Feb 2016.